These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 31738849)

  • 1. Successful treatment of hidradenitis suppurativa in the setting of Crohn disease with combination adalimumab and ustekinumab.
    Cline A; Pichardo RO
    Dermatol Online J; 2019 Sep; 25(9):. PubMed ID: 31738849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adalimumab treatment for hidradenitis suppurativa associated with Crohn's disease.
    Diamantova D; Lomickova I; Cetkovska P
    Acta Dermatovenerol Croat; 2014; 22(4):291-3. PubMed ID: 25580790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox?
    Martina E; Campanati A; Giuliodori K; Offidani A
    Acta Dermatovenerol Alp Pannonica Adriat; 2017 Mar; 26(1):21-23. PubMed ID: 28352932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience of the use of adalimumab in the management of hidradenitis suppurativa. Comparison of response rates with Crohn disease.
    Moyano B; Clemente A; Marín-Jiménez I; Martorell A
    Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():43-50. PubMed ID: 28081769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose, high-frequency ustekinumab therapy for patients with severe hidradenitis suppurativa.
    Jiang SW; Kwock JT; Liu B; Petty AJ; Zhao AT; Green CL; Jaleel T
    Br J Dermatol; 2022 Sep; 187(3):417-419. PubMed ID: 35192196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observational case series on adalimumab-induced paradoxical hidradenitis suppurativa.
    Delobeau M; Abdou A; Puzenat E; Deveza E; Biver-Dalle C; van de Laak A; Roche-Kubler B; Vuitton L; Koch S; Wendling D; Aubin F
    J Dermatolog Treat; 2016; 27(3):251-3. PubMed ID: 26368546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hidradenitis suppurativa and Crohn's disease: two cases that support an association.
    Yazdanyar S; Miller IM; Jemec GB
    Acta Dermatovenerol Alp Pannonica Adriat; 2010 Oct; 19(3):23-5. PubMed ID: 20976417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of co-existent SAPHO syndrome and hidradenitis suppurativa with adalimumab and methotrexate.
    Genovese G; Caorsi R; Moltrasio C; Marzano AV
    J Eur Acad Dermatol Venereol; 2019 Oct; 33 Suppl 6():40-41. PubMed ID: 31535768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview and update on biologic therapy for moderate-to-severe hidradenitis suppurativa.
    Porter ML; Golbari NM; Lockwood SJ; Kimball AB
    Semin Cutan Med Surg; 2018 Sep; 37(3):182-189. PubMed ID: 30215636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ustekinumab treatment for hidradenitis suppurativa.
    Takeda K; Kikuchi K; Kanazawa Y; Yamasaki K; Aiba S
    J Dermatol; 2019 Dec; 46(12):1215-1218. PubMed ID: 31638283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hidradenitis suppurativa and perianal Crohn disease: differential diagnosis.
    Bassas-Vila J; González Lama Y
    Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():27-31. PubMed ID: 28081767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ustekinumab for hidradenitis suppurativa: a case report.
    Santos-Pérez MI; García-Rodicio S; Del Olmo-Revuelto MA; Pozo-Román T
    Actas Dermosifiliogr; 2014 Sep; 105(7):720-2. PubMed ID: 24308927
    [No Abstract]   [Full Text] [Related]  

  • 13. Longitudinal observational study of hidradenitis suppurativa: impact of surgical intervention with adjunctive biologic therapy.
    Shanmugam VK; Mulani S; McNish S; Harris S; Buescher T; Amdur R
    Int J Dermatol; 2018 Jan; 57(1):62-69. PubMed ID: 29130482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hidradenitis suppurativa with infliximab in a patient with Crohn's disease.
    Rosi YL; Lowe L; Kang S
    J Dermatolog Treat; 2005 Feb; 16(1):58-61. PubMed ID: 15897171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination hyperbaric oxygen therapy and ustekinumab for severe hidradenitis suppurativa.
    Provini LE; Stellar JJ; Stetzer MN; Nguyen PD; Jen M
    Pediatr Dermatol; 2019 May; 36(3):381-383. PubMed ID: 30805965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant psoriasis and hidradenitis suppurativa responsive to adalimumab therapy: A case series.
    Yen CF; Huang YH; Chi CC
    Indian J Dermatol Venereol Leprol; 2021; 87(2):223-226. PubMed ID: 31389375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient.
    Katsanos KH; Christodoulou DK; Tsianos EV
    Am J Gastroenterol; 2002 Aug; 97(8):2155-6. PubMed ID: 12190206
    [No Abstract]   [Full Text] [Related]  

  • 18. Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. Comment on 'Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab'.
    Martora F; Fabbrocini G; Marasca C; Battista T; Megna M
    Clin Exp Dermatol; 2023 Jun; 48(6):701-703. PubMed ID: 36883596
    [No Abstract]   [Full Text] [Related]  

  • 19. SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate: a case report and review of the literature.
    Vekic DA; Woods J; Lin P; Cains GD
    Int J Dermatol; 2018 Jan; 57(1):10-18. PubMed ID: 28884797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HiSCR (Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study.
    Kimball AB; Sobell JM; Zouboulis CC; Gu Y; Williams DA; Sundaram M; Teixeira HD; Jemec GB
    J Eur Acad Dermatol Venereol; 2016 Jun; 30(6):989-94. PubMed ID: 26201313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.